COPD Exacerbations and Increased Cardiovascular Risk

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Nitin Seam, MD, assistant professor of medicine at George Washington University, talks with Anant Patel, MBBS, MRC clinical research fellow at the Center for Respiratory Medicine, University College London, and Mark Dransfield, MD, associate professor of medicine at UAB School of Medicine and medical director of the UAB Lung Health Center, about a new study of the link between acute exacerbations of COPD and cardiovascular risk.

To listen to this podcast, click here.
Related Articles
The 2013 American College of Cardiology/American Heart Association guidelines for determining statin eligibility more accurately identify increased risk of cardiovascular events.
Here are new drugs for 2015 that pharmacists can expect to handle.
Everyday walking is the most commonly reported problematic daily activity for patients with chronic obstructive pulmonary disease (COPD).
Warfarin remains a cornerstone anticoagulant for a number of reasons that include its low cost at the pharmacy counter.
Latest Issues
$auto_registration$